Rodgers Brothers’s GSK GSK Stock Holding History

Rodgers Brothers’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Hold	3,878	–	–	0.02%	245
2026 Q1	$214K	Buy	+3,878	New	+$210K	0.02%	234
2021 Q2	–	Sell	-12,266	Closed	-$547K	–	201
2021 Q1	$547K	Sell	12,266 -80	-0.6%	-$3.63K	0.11%	149
2020 Q4	$568K	Sell	12,346 -9,240	-43%	-$424K	0.13%	134
2020 Q3	$1.02M	Sell	21,586 -480	-2%	-$24.1K	0.26%	99
2020 Q2	$1.13M	Buy	+22,066	New	+$1.13M	0.3%	82
2017 Q4	–	Sell	-4,218	Closed	-$214K	–	177
2017 Q3	$214K	Buy	4,218 +6	+0.1%	+$304	0.08%	161
2017 Q2	$227K	Buy	4,212 +7	+0.2%	+$373	0.08%	159
2017 Q1	$222K	Buy	+4,205	New	+$213K	0.08%	157
2016 Q4	–	Sell	-8,036	Closed	-$433K	–	172
2016 Q3	$433K	Buy	+8,036	New	+$441K	0.17%	110

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Rodgers Brothers's GSK Position: Q2 2026 in Review

Rodgers Brothers held its GSK (GSK) position steady in Q2 2026 at 3,878 shares worth $203K. The position accounts for 0.02% of the portfolio, ranked #245.

Rodgers Brothers first reported a position in GSK in Q3 2016 and has held it in 10 quarters since. The position peaked at $1.13M in Q2 2020. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Rodgers Brothers held 3,878 shares of GSK worth $203K as of Q2 2026.
Rodgers Brothers left its GSK share count unchanged in Q2 2026.
GSK made up 0.02% of Rodgers Brothers's portfolio in Q2 2026, its #245 holding.
Rodgers Brothers first reported a position in GSK in Q3 2016 and has held it in 10 quarters since.
Rodgers Brothers's GSK position peaked at $1.13M in Q2 2020.
1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Rodgers Brothers's 13F filing for Q2 2026, filed 5 Aug 2026.